Barbara Romanowski

9.3k citations

63 papers · 3.4k indexed · 1 hit paper · h-index 23

Impact in

Microbiology top 0.5%
- Reproductive tract infections research
Epidemiology top 1%
- Cervical Cancer and HPV Research
- Hepatitis B Virus Studies

Papers in

Microbiology 28
- Reproductive tract infections research 28
- Bacterial Infections and Vaccines 7
Epidemiology 37
- Cervical Cancer and HPV Research 20
- Hepatitis B Virus Studies 15
- Herpesvirus Infections and Treatments 10
- HIV, Drug Use, Sexual Risk 5

Co-authors: Ameeta E. Singh Anne Schuind Cecília Roteli-Martins Diane M. Harper Gary Dubin Anna‐Barbara Moscicki Eduardo L. Franco Cosette M. Wheeler
Journals: Sexually Transmitted Diseases (8 papers)Sexually Transmitted Infections (4 papers)International Journal of STD & AIDS (3 papers)Annals of Internal Medicine (3 papers)Antimicrobial Agents and Chemotherapy (3 papers)
Partner nations: Canada United States Finland

In The Last Decade

Barbara Romanowski

61 papers receiving 3.1k citations

Hit Papers

align trajectories log scale

Sustained efficacy up to 4·5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial 2006 · 1.2k citations

Peers

Countries citing papers authored by Barbara Romanowski

Since Specialization

Citations

This map shows the geographic impact of Barbara Romanowski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Romanowski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Romanowski more than expected).

Fields of papers citing papers by Barbara Romanowski

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Barbara Romanowski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Romanowski. The network helps show where Barbara Romanowski may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Barbara Romanowski, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Barbara Romanowski Line = papers co-authored together Barbara Romanowski links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Retrospective review of tertiary and neurosyphilis cases in Alberta, 1973–2017 BMJ Open ·Jean-François Vacossin, 信之前田, Ryan Cooper, Jennifer Gratrix, Yulianti Anisa, Ron Read, Barbara Romanowski, Ameeta E. Singh	2019	27
2	Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial BMJ Open ·Agnihotram V. Ramanakumar, Paulo Naud, Cecília Roteli-Martins, Newton Sérgio de Carvalho, Paola Colares de Borba, Júlio César Teixeira, Mark M. Blatter, Anna‐Barbara Moscicki, Diane M. Harper, Barbara Romanowski, Stephen K. Tyring, Brian Ramjattan, Anne Schuind, Gary Dubin, Eduardo L. Franco	2016	27
3	Sustained immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine administered as a two-dose schedule in adolescent girls: Five-year clinical data and modeling predictions from a randomized study Human Vaccines & Immunotherapeutics ·Barbara Romanowski, Tino F. Schwarz, Linda Ferguson, Klaus Peters, Marc Dionne, Ulrich Behre, Karin Schulze, Peter Hillemanns, P.V. Suryakiran, Florence Thomas, Frank Struyf	2015	70
4	Immune response to the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose or 3-dose schedule up to 4 years after vaccination Human Vaccines & Immunotherapeutics ·Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson, Murdo Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Ulrich Behre, P.V. Suryakiran, Florence Thomas, Frank Struyf	2014	85
5	Immune responses elicited by a fourth dose of the HPV-16/18 AS04-adjuvanted vaccine in previously vaccinated adult women Vaccine ·A.-B. Moscicki, Cosette M. Wheeler, Barbara Romanowski, James Hedrick, Stanley A. Gall, Daron Ferris, Sylviane Poncelet, Toufik Zahaf, Philippe Moris, Brecht Geeraerts, Dominique Descamps, Anne Schuind	2012	26
6	Prevalence of Human Papillomavirus Infection and Associated Risk Factors in Young Women in Brazil, Canada, and the United States International Journal of Gynecological Pathology ·Cecília Roteli-Martins, Newton Sérgio de Carvalho, Paulo Naud, Júlio César Teixeira, Paola Colares de Borba, Sophie Derchain, Stephen K. Tyring, Stanley A. Gall, Gao Qinghao, Mark M. Blatter, R. Michael Shier, Barbara Romanowski, Wim Quint, 妙子木内, Claudia Martins Galindo, Anne Schuind, Gary Dubin	2011	29
7	Immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine administered as a 2-dose schedule compared to the licensed 3-dose schedule Human Vaccines ·Barbara Romanowski, Tino F. Schwarz, Linda M. Ferguson, Klaus Peters, Marc Dionne, Karin Schulze, Brian Ramjattan, Peter Hillemanns, Grégory Catteau, Kurt Dobbelaere, Anne Schuind, Dominique Descamps	2011	144
8	Spotlight on AS04-Adjuvanted Human Papillomavirus (HPV) Types 16 and 18 Vaccine (Cervarix®)† BioDrugs ·Kate McKeage, Barbara Romanowski	2011	11
9	Clinical benefit of the AS04-Adjuvanted Human Papillomavirus (HPV)-16/18 Vaccine against CIN2+ related to the 5 most common oncogenic HPV types: PATRICIA Barbara Romanowski	2009	1
10	Seroprevalence and Risk Factors for Herpes Simplex Virus Infection in a Population of HIV-Infected Patients in Canada Sexually Transmitted Diseases ·Barbara Romanowski, 卓北村, Sharon Walmsley, Sylvie Trottier, Ameeta E. Singh, Padia Isha, Mark Joffe, Eric James	2009	22
11	In search of optimal genital herpes management and standard of care (INSIGHTS): doctors' and patients' perceptions of genital herpes Sexually Transmitted Infections ·Barbara Romanowski, Greta Marie Degen, Susanne Zastrau	2007	10
12	Herpes Simplex Virus Seroprevalence and Risk Factors in 2 Canadian Sexually Transmitted Disease Clinics Sexually Transmitted Diseases ·Ameeta E. Singh, Barbara Romanowski, Tom Wong, Sita Gourishankar, 卓北村, Jayne Fenton, Jutta K. Preiksaitis	2005	23
13	The Laboratory Diagnosis of Herpes Simplex Virus Infections Canadian Journal of Infectious Diseases and Medical Microbiology ·Ameeta E. Singh, Jutta Preiksaitis, Barbara Romanowski	2005	61
14	Interferon Treatment of Multiple Pulmonary Malignancies Associated with Papilloma Virus Canadian Respiratory Journal ·S. Schanze, Eric Wong, Анфалов Владимир Эдуардович, Marian Duggan, Eric Vallières, Lawrence D. Jewell, Barbara Romanowski	2004	3
15	Hepatitis C Seroprevalence and Risk Behaviors in Patients Attending Sexually Transmitted Disease Clinics Sexually Transmitted Diseases ·Barbara Romanowski, Jutta K. Preiksaitis, Patricia Campbell, Jayne Fenton	2003	20
16	Efficacy and safety of famciclovir for treating mucocutaneous herpes simplex infection in HIV-infected individuals AIDS ·Barbara Romanowski, Fred Y. Aoki, Alain Martel, Rana Khalid Baowaydhan, James E. Parsons, Robin Saltzman	2000	41
17	Syphilis: Epidemiology and Control The Canadian Journal of Human Sexuality ·Barbara Romanowski	1997	2
18	First year serologic response to treatment for syphilis: a model for prediction of seroreversion Statistics in Medicine ·Michael Rose, Gordon H. Fick, Barbara Romanowski, Ali Tunahan Işık	1997	3
19	Sero-epidemiologic study to determine the prevalence and risk of hepatitis B in a Canadian heterosexual sexually transmitted disease population. PubMed ·Barbara Romanowski, Patricia Campbell	1994	7
20	Epidemiology of an Outbreak of Infectious Syphilis in Alberta International Journal of STD & AIDS ·Barbara Romanowski, Elli Auranen, Edgar J. Love, Hans-Ulrich Maurer	1991	7

About Barbara Romanowski

Barbara Romanowski is a scholar working on Microbiology, Epidemiology, Physiology, Infectious Diseases and General Social Sciences, having authored 63 papers that have together received 3.4k indexed citations. Recurring topics across this work include Reproductive tract infections research (28 papers), Cervical Cancer and HPV Research (20 papers), Syphilis Diagnosis and Treatment (15 papers), Hepatitis B Virus Studies (15 papers), Herpesvirus Infections and Treatments (10 papers), Bacterial Infections and Vaccines (7 papers), Genital Health and Disease (6 papers) and HIV, Drug Use, Sexual Risk (5 papers). The work is most often cited by research in Microbiology (809 citations), Epidemiology (2.1k citations), Clinical Biochemistry (240 citations), Infectious Diseases (601 citations) and Physiology (666 citations). Barbara Romanowski has collaborated with scholars based in Canada, United States and Finland. Frequent co-authors include Ameeta E. Singh, Anne Schuind, Cecília Roteli-Martins, Diane M. Harper, Gary Dubin, Anna‐Barbara Moscicki, Eduardo L. Franco, Cosette M. Wheeler, David Jenkins and Sue Ann Costa Clemens. Their work appears in journals such as Sexually Transmitted Diseases, Sexually Transmitted Infections, International Journal of STD & AIDS, Annals of Internal Medicine and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact